Spruce Biosciences Inc Sustainability Reports
A late-stage biopharmaceutical company focused on developing and commercializing novel therapies for rare endocrine and neurological disorders with significant unmet medical needs.
Sector: Manufacturing
Country: United States
Exchange: OTC Markets
1 reports from 2020 to 2020
Company Profile
A late-stage biopharmaceutical company focused on developing and commercializing novel therapies for rare endocrine and neurological disorders with significant unmet medical needs.
Reports
1 total
Limited sustainability disclosure available
This company only publishes Annual Reports without dedicated sustainability sections.
Years